Integra LifeSciences Holdings Corporation (NASDAQ: IART) is one of 84 publicly-traded companies in the “Medical Equipment, Supplies & Distribution” industry, but how does it contrast to its rivals? We will compare Integra LifeSciences Holdings Corporation to related companies based on the strength of its institutional ownership, dividends, risk, analyst recommendations, earnings, profitability and valuation.

Volatility & Risk

Integra LifeSciences Holdings Corporation has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500. Comparatively, Integra LifeSciences Holdings Corporation’s rivals have a beta of 1.02, suggesting that their average share price is 2% more volatile than the S&P 500.

Profitability

This table compares Integra LifeSciences Holdings Corporation and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Integra LifeSciences Holdings Corporation 4.52% 16.35% 6.83%
Integra LifeSciences Holdings Corporation Competitors -126.38% -36.21% -9.85%

Analyst Ratings

This is a breakdown of recent ratings and target prices for Integra LifeSciences Holdings Corporation and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integra LifeSciences Holdings Corporation 0 4 6 0 2.60
Integra LifeSciences Holdings Corporation Competitors 181 1155 2523 90 2.64

Integra LifeSciences Holdings Corporation presently has a consensus target price of $53.11, indicating a potential upside of 10.14%. As a group, “Medical Equipment, Supplies & Distribution” companies have a potential downside of 0.43%. Given Integra LifeSciences Holdings Corporation’s higher possible upside, equities analysts clearly believe Integra LifeSciences Holdings Corporation is more favorable than its rivals.

Earnings and Valuation

This table compares Integra LifeSciences Holdings Corporation and its rivals revenue, earnings per share and valuation.

Gross Revenue NetIncome Price/Earnings Ratio
Integra LifeSciences Holdings Corporation $992.08 $74.56 79.05
Integra LifeSciences Holdings Corporation Competitors $412.32 million $113.71 million 88.64

Integra LifeSciences Holdings Corporation’s rivals have higher revenue and earnings than Integra LifeSciences Holdings Corporation. Integra LifeSciences Holdings Corporation is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

84.9% of Integra LifeSciences Holdings Corporation shares are held by institutional investors. Comparatively, 66.9% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by institutional investors. 21.5% of Integra LifeSciences Holdings Corporation shares are held by company insiders. Comparatively, 11.5% of shares of all “Medical Equipment, Supplies & Distribution” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Integra LifeSciences Holdings Corporation rivals beat Integra LifeSciences Holdings Corporation on 7 of the 13 factors compared.

Integra LifeSciences Holdings Corporation Company Profile

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions. It sells products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care. It also sells regenerative technology products for treating acute wounds, such as burns, and chronic wounds, including diabetic foot ulcers and surgical tissue repair. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery.

Receive News & Ratings for Integra LifeSciences Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra LifeSciences Holdings Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.